Literature DB >> 24756862

Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma.

Benito Campos1, Zoltan Gal, Aline Baader, Tilman Schneider, Christopher Sliwinski, Kristina Gassel, Josephine Bageritz, Niels Grabe, Andreas von Deimling, Philipp Beckhove, Carolin Mogler, Violaine Goidts, Andreas Unterberg, Volker Eckstein, Christel Herold-Mende.   

Abstract

Cancer cells with enhanced self-renewal capacity influence tumour growth in glioblastoma. So far, a variety of surrogate markers have been proposed to enrich these cells, emphasizing the need to devise new characterization methods. Here, we screen a large panel of glioblastoma cultures (n = 21) cultivated under stem cell-permissive conditions and identify several cell lines with enhanced self-renewal capacity. These cell lines are capable of matrix-independent growth and form fast-growing, orthotopic tumours in mice. Employing isolation, re-plating, and label-retention techniques, we show that self-renewal potential of individual cells is partitioned asymmetrically between daughter cells in a robust and cell line-specific fashion. This yields populations of fast- and slow-cycling cells, which differ in the expression of cell cycle-associated transcripts. Intriguingly, fast-growing cells keep their slow-cycling counterparts in a reversible state of quiescence associated with high chemoresistance. Our results suggest that two different subpopulations of tumour cells contribute to aberrant growth and tumour recurrence after therapy in glioblastoma.
Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  self-renewal; glioblastoma; label retention; quiescence

Mesh:

Year:  2014        PMID: 24756862     DOI: 10.1002/path.4366

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  22 in total

1.  Time-lapse microscopic observation of non-dividing cells in cultured human osteosarcoma MG-63 cell line.

Authors:  John Dosch; Elise Hadley; Cal Wiese; Marissa Soderberg; Tori Houwman; Kai Ding; Alexandra Kharazova; John L Collins; Bart van Knippenberg; Carl Gregory; Alexander Kofman
Journal:  Cell Cycle       Date:  2017-12-26       Impact factor: 4.534

2.  Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.

Authors:  Guoxin Zhang; Zhen Dong; Briana C Prager; Leo Jk Kim; Qiulian Wu; Ryan C Gimple; Xiuxing Wang; Shideng Bao; Petra Hamerlik; Jeremy N Rich
Journal:  JCI Insight       Date:  2019-04-04

3.  Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma.

Authors:  Lan B Hoang-Minh; Florian A Siebzehnrubl; Changlin Yang; Silveli Suzuki-Hatano; Kyle Dajac; Tyler Loche; Nicholas Andrews; Michael Schmoll Massari; Jaimin Patel; Krisha Amin; Alvin Vuong; Ana Jimenez-Pascual; Paul Kubilis; Timothy J Garrett; Craig Moneypenny; Christina A Pacak; Jianping Huang; Elias J Sayour; Duane A Mitchell; Matthew R Sarkisian; Brent A Reynolds; Loic P Deleyrolle
Journal:  EMBO J       Date:  2018-10-15       Impact factor: 11.598

Review 4.  A comprehensive profile of recurrent glioblastoma.

Authors:  B Campos; L R Olsen; T Urup; H S Poulsen
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

Review 5.  Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis.

Authors:  Sukanya Basu; Yang Dong; Rahul Kumar; Collene Jeter; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2021-05-09       Impact factor: 15.707

6.  Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes.

Authors:  Carlo Cusulin; Charles Chesnelong; Pinaki Bose; Misha Bilenky; Karen Kopciuk; Jennifer A Chan; J Gregory Cairncross; Steven J Jones; Marco A Marra; H Artee Luchman; Samuel Weiss
Journal:  Stem Cell Reports       Date:  2015-06-18       Impact factor: 7.765

7.  Cancer stem cell theory and the warburg effect, two sides of the same coin?

Authors:  Nicola Pacini; Fabio Borziani
Journal:  Int J Mol Sci       Date:  2014-05-19       Impact factor: 5.923

8.  The Quiescent Metabolic Phenotype of Glioma Stem Cells.

Authors:  Elizabeth I Spehalski; Jennifer A Lee; Cord Peters; Philip Tofilon; Kevin Camphausen
Journal:  J Proteomics Bioinform       Date:  2019-08-13

9.  A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma.

Authors:  Obada T Alhalabi; Michael N C Fletcher; Thomas Hielscher; Tobias Kessler; Tolga Lokumcu; Ulrich Baumgartner; Elena Wittmann; Silja Schlue; Mona Göttmann; Shaman Rahman; Ling Hai; Lea Hansen-Palmus; Laura Puccio; Ichiro Nakano; Christel Herold-Mende; Bryan W Day; Wolfgang Wick; Felix Sahm; Emma Phillips; Violaine Goidts
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 13.029

Review 10.  Targeting Aggressive Cancer Stem Cells in Glioblastoma.

Authors:  Tracy Seymour; Anna Nowak; Foteini Kakulas
Journal:  Front Oncol       Date:  2015-07-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.